Less false-negative sentinel node procedures in melanoma patients with experience and proper collaboration

Journal of Surgical Oncology

Volumn 104, Issue 5, 2011, Pages 454-457

  Veenstra, Hidde J ^a   Wouters, Michel J W M ^a   Kroon, Bin B R ^a   Olmos, Renato A Valdés ^a   Nieweg, Omgo E ^a  

^a ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

Author keywords

false negative; sentinel node biopsy; skin malignancies

Indexed keywords

ARTICLE; CANCER RECURRENCE; FALSE NEGATIVE RESULT; HUMAN; HUMAN TISSUE; LYMPH NODE BIOPSY; MAJOR CLINICAL STUDY; MELANOMA; PRIORITY JOURNAL; SENTINEL LYMPH NODE;

COHORT STUDIES; FALSE NEGATIVE REACTIONS; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MELANOMA; NEOPLASM STAGING; PROGNOSIS; RESEARCH DESIGN; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS;

EID: 79961053118     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21967     Document Type: Article

References (37)

1. Jansen L, Nieweg OE, Peterse JL, et al.: Reliability of sentinel lymph node biopsy for staging melanoma. Br J Surg 2000; 87: 484-489. (Pubitemid 30192962)
2. Morton DL, Thompson JF, Essner R, et al.: Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: A multicenter trial. Multicenter Selective Lymphadenectomy Trial Group. Ann Surg 1999; 230: 453-463.
3. Nieweg OE, Tanis PJ, Rutgers EJH,: Summary of the Second International Sentinel Node Conference. Eur J Nucl Med 2001; 28: 646-649.
4. Morton DL, Wen DR, Wong JH, et al.: Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992; 127: 392-399.
5. Reintgen D, Cruse CW, Wells K, et al.: The orderly progression of melanoma nodal metastases. Ann Surg 1994; 220: 759-767. (Pubitemid 24376374)
6. Thompson JF, McCarthy WH, Bosch CM, et al.: Sentinel lymph node status as an indicator of the presence of metastatic melanoma in regional lymph nodes. Melanoma Res 1995; 5: 255-260.
7. Gershenwald JE, Thompson W, Mansfield PF, et al.: Multi-institutional melanoma lymphatic mapping experience: The prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol 1999; 17: 976-983. (Pubitemid 29109331)
8. Morton DL, Thompson JF, Cochran AJ, et al.: Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med 2006; 355: 1307-1317. (Pubitemid 44465459)
9. Nieweg OE, Estourgie SH,: What is a sentinel node and what is a false-negative sentinel node? Ann Surg Oncol 2004; 11: 169S-173S.
10. Clary BM, Brady MS, Lewis JJ, et al.: Sentinel lymph node biopsy in the management of patients with primary cutaneous melanoma: Review of a large single-institutional experience with an emphasis on recurrence. Ann Surg 2001; 233: 250-258. (Pubitemid 32106080)
11. Scoggins CR, Martin RC, Ross MI, et al.: Factors associated with false-negative sentinel lymph node biopsy in melanoma patients. Ann Surg Oncol 2010; 17: 709-717.
12. Gershenwald JE, Colome MI, Lee JE, et al.: Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma. J Clin Oncol 1998; 16: 2253-2260. (Pubitemid 28265065)
13. Yee VS, Thompson JF, McKinnon JG, et al.: Outcome in 846 cutaneous melanoma patients from a single center after a negative sentinel node biopsy. Ann Surg Oncol 2005; 12: 429-439. (Pubitemid 40884257)
14. Leiter U, Buettner PG, Bohnenberger K, et al.: Sentinel lymph node dissection in primary melanoma reduces subsequent regional lymph node metastasis as well as distant metastasis after nodal involvement. Ann Surg Oncol 2010; 17: 129-137.
15. Doting MH, Hoekstra HJ, Plukker JT, et al.: Is sentinel node biopsy beneficial in melanoma patients? A report on 200 patients with cutaneous melanoma. Eur J Surg Oncol 2002; 28: 673-678.
16. Vuylsteke RJ, Van Leeuwen PA, StatiusMuller MG, et al.: Clinical outcome of stage I/II melanoma patients after selective sentinel lymph node dissection: Long-term follow-up results. J Clin Oncol 2003; 21: 1057-1065. (Pubitemid 46594135)
17. Van Akkooi AC, De Wilt JH, Verhoef C, et al.: High positive sentinel node identification rate by EORTC melanoma group protocol. Prognostic indicators of metastatic patterns after sentinel node biopsy in melanoma. Eur J Cancer 2006; 42: 372-380. (Pubitemid 43132893)
18. Karim RZ, Scolyer RA, Li W, et al.: False negative sentinel lymph node biopsies in melanoma may result from deficiencies in nuclear medicine, surgery, or pathology. Ann Surg 2008; 247: 1003-1010. (Pubitemid 351770421)
19. Estourgie SH, Nieweg OE, Valdés Olmos RA, et al.: Review and evaluation of sentinel node procedures in 250 melanoma patients with a median follow-up of 6 years. Ann Surg Oncol 2003; 10: 681-688. (Pubitemid 40486901)
20. Van der Ploeg IM, Valdés Olmos RA, Nieweg OE, et al.: The additional value of SPECT/CT in lymphatic mapping in breast cancer and melanoma. J Nucl Med 2007; 48: 1756-1760. (Pubitemid 350099318)
21. Nieweg OE, Tanis PJ, Kroon BBR,: The definition of a sentinel node. Ann Surg Oncol 2001; 8: 538-541. (Pubitemid 32642611)
22. Van der Ploeg IM, Kroon BBR, Antonini N, et al.: Is completion lymph node dissection needed in case of minimal melanoma metastasis in the sentinel node? Ann Surg 2009; 249: 1003-1007.
23. Van der Ploeg IM, Kroon BBR, Antonini N, et al.: Comparison of three micromorphometric pathology classifications of melanoma metastases in the sentinel node. In Press 2009.
24. Nieweg OE, Tanis PJ, de Vries JD, et al.: Sensitivity of sentinel node biopsy in melanoma. J Surg Oncol 2001; 78: 223-224. (Pubitemid 33097049)
25. Caraco C, Marone U, Celentano E, et al.: Impact of false-negative sentinel lymph node biopsy on survival in patients with cutaneous melanoma. Ann Surg Oncol 2007; 14: 2662-2667. (Pubitemid 47389571)
26. Leiter U, Garbe C,: In reply: Sentinel lymph node biopsy in melanoma. Ann Surg Oncol 2011; 18: 598-599.
27. Kapteijn BA, Nieweg OE, Valdés Olmos RA, et al.: Reproducibility oflymphoscintigraphy for lymphatic mapping in cutaneous melanoma. J Nucl Med 1996; 37: 972-975. (Pubitemid 126447132)
28. Mudun A, Murray DR, Herda SC, et al.: Early stage melanoma: Lymphoscintigraphy, reproducibility of sentinel node detection, and effectiveness of the intraoperative gamma probe. Radiology 1996; 199: 171-175. (Pubitemid 26095833)
29. Leijte JA, Van der Ploeg IM, Valdés OlmosRA, et al.: Visualization of tumor blockage and rerouting of lymphatic drainage in penile cancer patients by use of SPECT/CT. J Nucl Med 2009; 50: 364-367.
30. Lam TK, Uren RF, Scolyer RA, et al.: False-negative sentinel node biopsy because of obstruction of lymphatics by metastatic melanoma: The value of ultrasound in conjunction with preoperative lymphoscintigraphy. Melanoma Res 2009; 19: 94-99.
31. Nieweg OE,: False-negative sentinel node biopsy. Ann Surg Oncol 2009; 16: 2089-2091.
32. Van der Ploeg IM, Valdés Olmos RA, Kroon BBR, et al.: The yield of SPECT/CT for anatomical lymphatic mapping in patients with melanoma. Ann Surg Oncol 2009; 16: 1537-1542.
33. Martinez SR, Mori T, Hoon DS,: Molecular upstaging of sentinel lymph nodes in melanoma: Where are we now? Surg Oncol Clin N Am 2006; 15: 331-340.
34. Palmieri G, Ascierto PA, Cossu A, et al.: Detection of occult melanoma cells in paraffin-embedded histologically negative sentinel lymph nodes using a reverse transcriptase polymerase chain reaction assay. J Clin Oncol 2001; 19: 1437-1443. (Pubitemid 32202551)
35. Scolyer RA, Murali R, McCarthy SW, et al.: Pathologic examination of sentinel lymph nodes from melanoma patients. Semin Diagn Pathol 2008; 25: 100-111. (Pubitemid 351885456)
36. Haigh PI, Lucci A, Turner RR, et al.: Carbon dye histologically confirms the identity of sentinel lymph nodes in cutaneous melanoma. Cancer 2001; 92: 535-541. (Pubitemid 32735188)
37. Morton DL, Hoon DS, Cochran AJ, et al.: Lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: Therapeutic utility and implications of nodal microanatomy and molecular staging for improving the accuracy of detection of nodal micrometastases. Ann Surg 2003; 238: 538-549.